HU176215B - Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 - Google Patents

Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 Download PDF

Info

Publication number
HU176215B
HU176215B HU78CI1803A HUCI001803A HU176215B HU 176215 B HU176215 B HU 176215B HU 78CI1803 A HU78CI1803 A HU 78CI1803A HU CI001803 A HUCI001803 A HU CI001803A HU 176215 B HU176215 B HU 176215B
Authority
HU
Hungary
Prior art keywords
indomethacin
cyclodextrin
complex
animals
inclusion complex
Prior art date
Application number
HU78CI1803A
Other languages
English (en)
Hungarian (hu)
Inventor
Jozsef Szejtli
Lajos Szente
Agoston David
Sandor Virag
Gyula Sebesteny
Attila Mandi
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to HU78CI1803A priority Critical patent/HU176215B/hu
Priority to NL7808792A priority patent/NL7808792A/xx
Priority to IL56309A priority patent/IL56309A/xx
Priority to IT67050/79A priority patent/IT1118282B/it
Priority to SE7900479A priority patent/SE445353B/sv
Priority to CS79445A priority patent/CS207742B2/cs
Priority to DE19792902297 priority patent/DE2902297A1/de
Priority to FI790198A priority patent/FI65441C/fi
Priority to FR7901796A priority patent/FR2415631A1/fr
Priority to US06/006,185 priority patent/US4228160A/en
Priority to AU43671/79A priority patent/AU518750B2/en
Priority to JP765679A priority patent/JPS54117018A/ja
Priority to GB7902710A priority patent/GB2016499B/en
Priority to DD79210634A priority patent/DD141312A1/de
Priority to NO790261A priority patent/NO146637C/no
Priority to BE193088A priority patent/BE873725A/xx
Priority to ES477181A priority patent/ES477181A1/es
Priority to DK035079A priority patent/DK154977C/da
Priority to AT59179A priority patent/AT360554B/de
Priority to CH81779A priority patent/CH638819A5/de
Priority to PL1979213015A priority patent/PL117208B1/pl
Priority to CA000320353A priority patent/CA1119115A/en
Priority to SU792718201A priority patent/SU915807A3/ru
Publication of HU176215B publication Critical patent/HU176215B/hu

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HU78CI1803A 1978-01-27 1978-01-27 Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 HU176215B (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
HU78CI1803A HU176215B (en) 1978-01-27 1978-01-27 Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1
NL7808792A NL7808792A (nl) 1978-01-27 1978-08-25 Insluitcomplex van cyclodextrine en indomethacine, en farmaceutisch preparaat daarvan alsmede werkwijzen voor het bereiden van een en ander.
IL56309A IL56309A (en) 1978-01-27 1978-12-26 Inclusion complex of cyclodextrin and indomethacin,its preparation and pharmaceutical compositions containing them
IT67050/79A IT1118282B (it) 1978-01-27 1979-01-11 Complesso ad inclusione fra ciclodestrina ed indometacina e procedimento per la loro preparazione
SE7900479A SE445353B (sv) 1978-01-27 1979-01-18 Inneslutningskomplex baserat pa cyklodextrin och indometacin, sett att framstella komplexet samt farmaceutisk beredning derav
CS79445A CS207742B2 (en) 1978-01-27 1979-01-19 Method of makingthe inclusion complex of the cyclodextrin and acid 1-/p-chlorbenzoyl/-5-methoxy-2-methylind-3-yl-vinegar
DE19792902297 DE2902297A1 (de) 1978-01-27 1979-01-22 Inklusionskomplex des cyclodextrins mit indomethacin und verfahren zur herstellung des komplexes
FI790198A FI65441C (fi) 1978-01-27 1979-01-22 Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin
FR7901796A FR2415631A1 (fr) 1978-01-27 1979-01-24 Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation
US06/006,185 US4228160A (en) 1978-01-27 1979-01-24 Inclusion complex of cyclodextrin and indomethacin and a process for the preparation thereof, method of use and pharmaceutical composition
AU43671/79A AU518750B2 (en) 1978-01-27 1979-01-25 Inclusion complex of cyclodextrin and indomethacin
JP765679A JPS54117018A (en) 1978-01-27 1979-01-25 Coacervated complex of cyclodextrin and indomethacine and production
GB7902710A GB2016499B (en) 1978-01-27 1979-01-25 Inclusion complexes of indomethacin their preparation and pharmaceutical compositions containing them
DD79210634A DD141312A1 (de) 1978-01-27 1979-01-25 Verfahren zur herstellung eines inklusionskomplexes von cyclodextrin mit indomethacin
NO790261A NO146637C (no) 1978-01-27 1979-01-26 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt inklusjonskompleks av cyclodextrin og 1-(p-klorbenzoyl)-5-methoxy-2-methyl-indol-3-yl-eddiksyre
BE193088A BE873725A (fr) 1978-01-27 1979-01-26 Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation
ES477181A ES477181A1 (es) 1978-01-27 1979-01-26 Procedimiento para la preparacion de complejos de inclusion de ciclodextrina.
DK035079A DK154977C (da) 1978-01-27 1979-01-26 Analogifremgangsmaade til fremstilling af et inklusionskompleks af cyclodextrin og aeindomethacinae
AT59179A AT360554B (de) 1978-01-27 1979-01-26 Verfahren zur herstellung eines neuen inklusionskomplexes von cyclodextrin mit indometacin
CH81779A CH638819A5 (de) 1978-01-27 1979-01-26 Inklusionskomplex des cyclodextrins mit indomethacin und verfahren zur herstellung des komplexes.
PL1979213015A PL117208B1 (en) 1978-01-27 1979-01-26 Process for preparing novel inclusion complexes of cyclodextrin and indometacineodekstrina i indometacina
CA000320353A CA1119115A (en) 1978-01-27 1979-01-26 Inclusion complex of cyclodextrin and indomethacin and a process for the preparation thereof
SU792718201A SU915807A3 (en) 1978-01-27 1979-01-26 Process for producing derivatives of cyclodextrin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78CI1803A HU176215B (en) 1978-01-27 1978-01-27 Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1

Publications (1)

Publication Number Publication Date
HU176215B true HU176215B (en) 1981-01-28

Family

ID=10994689

Family Applications (1)

Application Number Title Priority Date Filing Date
HU78CI1803A HU176215B (en) 1978-01-27 1978-01-27 Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1

Country Status (23)

Country Link
US (1) US4228160A (US06272168-20010807-M00014.png)
JP (1) JPS54117018A (US06272168-20010807-M00014.png)
AT (1) AT360554B (US06272168-20010807-M00014.png)
AU (1) AU518750B2 (US06272168-20010807-M00014.png)
BE (1) BE873725A (US06272168-20010807-M00014.png)
CA (1) CA1119115A (US06272168-20010807-M00014.png)
CH (1) CH638819A5 (US06272168-20010807-M00014.png)
CS (1) CS207742B2 (US06272168-20010807-M00014.png)
DD (1) DD141312A1 (US06272168-20010807-M00014.png)
DE (1) DE2902297A1 (US06272168-20010807-M00014.png)
DK (1) DK154977C (US06272168-20010807-M00014.png)
ES (1) ES477181A1 (US06272168-20010807-M00014.png)
FI (1) FI65441C (US06272168-20010807-M00014.png)
FR (1) FR2415631A1 (US06272168-20010807-M00014.png)
GB (1) GB2016499B (US06272168-20010807-M00014.png)
HU (1) HU176215B (US06272168-20010807-M00014.png)
IL (1) IL56309A (US06272168-20010807-M00014.png)
IT (1) IT1118282B (US06272168-20010807-M00014.png)
NL (1) NL7808792A (US06272168-20010807-M00014.png)
NO (1) NO146637C (US06272168-20010807-M00014.png)
PL (1) PL117208B1 (US06272168-20010807-M00014.png)
SE (1) SE445353B (US06272168-20010807-M00014.png)
SU (1) SU915807A3 (US06272168-20010807-M00014.png)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606074A (en) * 1946-08-21 1952-08-05 Edward H Ackermann Air distributing nozzle
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
DE2947742C2 (de) * 1979-11-27 1986-04-03 Koch, Jürgen, Dr., 2000 Hamburg Arzneimittel, enthaltend β-Cyclodextrin
HU184066B (en) * 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
HU181733B (en) * 1980-08-07 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing sorbents containing cyclodextrin on cellulose base
HU182217B (en) * 1980-10-17 1983-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing inclusive complexes of cyclodextrines and strong inorganic oxyacids
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
HU183430B (en) * 1981-05-12 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
US4425336A (en) 1982-05-24 1984-01-10 Key Pharmaceuticals, Inc. 3,4-Dihydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexes
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
HU190818B (en) * 1982-11-09 1986-11-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing complexes of piperonyl-butoxide-cyclodextrin
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
US4502930A (en) * 1983-06-27 1985-03-05 Agency Of Industrial Science & Technology Method for manufacture of 7-substituted quadricyclene-cyclodextrin inclusion compound
JPS6025967A (ja) * 1983-07-21 1985-02-08 Eisai Co Ltd トリパミド包接化合物
US4675395A (en) * 1984-03-14 1987-06-23 Seiwa Technological Laboratories Limited Cyclodextrin inclusion compound and process for its preparation
JPS60202115A (ja) * 1984-03-27 1985-10-12 Ichiro Shibauchi エポキシ樹脂用硬化剤
DE3427787A1 (de) * 1984-07-27 1986-01-30 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Wirkstoffkomplexe von 5-methoxy-2((4-methoxy-3,5-dimethyl-2-pyridyl) methylsulfinyl)-1h-benzimidazol mit cyclodextrinen, deren herstellung und arzneimittel
YU43290B (en) * 1986-11-13 1989-06-30 Lek Tovarna Farmacevtskih Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US4885275A (en) * 1987-10-15 1989-12-05 Eli Lilly And Company Vancomycin-HCL solutions and the lyophilization thereof
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
DE3809808A1 (de) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
US5139687A (en) * 1990-05-09 1992-08-18 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5246611A (en) * 1990-05-09 1993-09-21 The Procter & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5384186A (en) * 1990-05-09 1995-01-24 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
JPH07583B2 (ja) * 1990-11-21 1995-01-11 北海道糖業株式会社 水溶性五環性トリテルペン包接化合物及びその製造方法並びにそれを利用した食品、飲料、口腔用組成物
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
US5602112A (en) 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5403828A (en) * 1992-08-13 1995-04-04 American Maize-Products Company Purification of cyclodextrin complexes
CA2190598A1 (en) * 1994-05-27 1995-12-07 Lawrence John Penkler Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
US6287603B1 (en) 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
KR100473716B1 (ko) * 2002-03-27 2005-03-08 주식회사 참 존 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법
WO2006137959A1 (en) * 2005-06-13 2006-12-28 Cargill, Incorporated Cyclodextrin inclusion complexes and methods of preparing same
US20090029020A1 (en) * 2005-06-13 2009-01-29 Cargill, Incorporated Cyclodextrin inclusion complexes and methods of preparing same
US20070009531A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010486A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010478A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
CA2654799A1 (en) * 2006-06-13 2007-12-21 Cargill, Incorporated Large-particle cyclodextrin inclusion complexes and methods of preparing same
MX2009007084A (es) * 2006-12-27 2009-08-20 Cargill Inc Complejos de inclusion de ciclodextrina y metodos para preparar los mismos.
US20080283693A1 (en) * 2007-05-15 2008-11-20 Evans Michael J F Propulsion apparatus and system
WO2009144927A1 (ja) * 2008-05-27 2009-12-03 富士フイルム株式会社 薬剤含有組成物
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
WO2017136775A1 (en) * 2016-02-04 2017-08-10 Czap Research And Development, Llc Controlled-release and stratified cyclodextrin inclusion complex vehicles
CN107158403B (zh) * 2017-05-18 2020-09-08 宁夏蓝博思化学技术有限公司 异甘草素-环糊精或环糊精衍生物包合物及组合物及制备方法及用途
CN107184989B (zh) * 2017-05-18 2020-09-08 宁夏蓝博思化学技术有限公司 甘草素-环糊精或环糊精衍生物包合物及组合物及制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959580A (en) * 1956-10-17 1960-11-08 Univ Minnesota Formation of inclusion compounds
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents
DE1620031B1 (de) 1961-03-22 1971-04-08 Merck & Co Inc Indolyl-(3)-alkancarbonsäuren
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin

Also Published As

Publication number Publication date
NL7808792A (nl) 1979-07-31
CS207742B2 (en) 1981-08-31
PL213015A1 (pl) 1979-12-17
DE2902297A1 (de) 1979-08-02
AU4367179A (en) 1979-08-02
BE873725A (fr) 1979-05-16
IT1118282B (it) 1986-02-24
DD141312A1 (de) 1980-04-23
ATA59179A (de) 1980-06-15
DE2902297C2 (US06272168-20010807-M00014.png) 1989-02-09
FR2415631A1 (fr) 1979-08-24
AT360554B (de) 1981-01-26
CH638819A5 (de) 1983-10-14
IT7967050A0 (it) 1979-01-11
PL117208B1 (en) 1981-07-31
FI790198A (fi) 1979-07-28
ES477181A1 (es) 1979-10-16
SU915807A3 (en) 1982-03-23
FR2415631B1 (US06272168-20010807-M00014.png) 1981-12-24
CA1119115A (en) 1982-03-02
US4228160A (en) 1980-10-14
DK35079A (da) 1979-07-28
DK154977B (da) 1989-01-16
FI65441B (fi) 1984-01-31
NO146637B (no) 1982-08-02
NO146637C (no) 1982-11-10
FI65441C (fi) 1984-05-10
JPS54117018A (en) 1979-09-11
SE445353B (sv) 1986-06-16
GB2016499B (en) 1982-07-28
DK154977C (da) 1989-06-12
AU518750B2 (en) 1981-10-15
GB2016499A (en) 1979-09-26
IL56309A (en) 1981-09-13
NO790261L (no) 1979-07-30
SE7900479L (sv) 1979-07-28

Similar Documents

Publication Publication Date Title
HU176215B (en) Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1
US4603123A (en) Compounds having antiinflammatory activity, obtained by complexation of piroxican with β-cyclodextrin, and pharmaceutical compositions containing them
US4518588A (en) Process for the preparation of an inclusion complex of N-(1--phenylethyl)-3,3-diphenylpropylamine and the hydrochloride thereof respectively with cyclodextrin
NZ288150A (en) Nimesulide(n-(4-nitro-2-phenoxyphenyl)methanesulphonamide) salt with l-lysine; complexes with cyclodextrins; pharmaceutical compositions
HU213401B (en) Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it
EP0422497B1 (en) Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them
HU209308B (en) Process for producing codeine salt of substituted carboxylic acid
RU2198167C2 (ru) Кристаллические модификации 1-(2,6-дифторбензил)-1н-1,2,3-триазол-4-карбоксамида и фармацевтическая композиция
CN108239185A (zh) 一种奎尼丁与胺类环糊精的包合物
US4113744A (en) Microcrystalline 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin (warfarin) and methods of making
KR0133075B1 (ko) 소화성 궤양 질환 치료용 치료학적 제제
JPH10182639A (ja) ドキサゾシン・メシレートの新規な形態ｉ
HU187626B (en) Process for preparing vincamine saccharinate
US6984632B1 (en) Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
US5254728A (en) Complexes containing S(+)-phenyl alkanoic acids and α-hydroxyalkanoic
JPS62120344A (ja) ４−ビフエニリル酢酸エステル−シクロデキストリン包接化合物
JPS60152462A (ja) インド−ル酢酸アミド誘導体の製造方法
RU2108109C1 (ru) Способ получения комплекса силибинина с циклодекстрином, комплекс включения силибинина с циклодекстрином, фармацевтическая композиция антигепатотоксической активности и способ ее получения
US7001886B2 (en) Hot melt method for preparing diphenhydramine tannate
EP0449722B1 (fr) Nouveaux complexes de l'acide tiaprofénique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs dérivés
JPS6330462A (ja) 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤
JPS59216899A (ja) ２′―デオキシ―５―トリフルオロメチルウリジン誘導体及びそれを含む抗腫瘍剤
US7683042B1 (en) Stabilized halide-free glucosamine base and method of preparation
JPH1129465A (ja) 抗潰瘍剤
EP0153171A2 (en) New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee